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Dr William D. Jordan (Birmingham, Ala). Dr Goodney has
reported a 5-year series of carotid endarterectomy from the Vascu-
lar Study Group of New England (VSGNE), and analyzed theperformed 4465 operations for primary carotid stenosis, or 13
operations per surgeon per year—not an enormous number. How-
ever, 175 or 3.5% died and were not available for the surveillance
study. Additionally, nearly 1000 did not have 1-year data, leaving
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recurrent stenosis, likely asymptomatic, and only one-quarter re-
quired reintervention within that period, that is a paltry number
considering this large series. Now, considering the increased pres-
sure for “value-based medicine” (aka, a Washington bureaucrat
telling us when to order a study or when to do an operation), is it
really worthwhile to intensely survey these patients? Can we show
a value in postoperative scanning when the need for reintervention
is so low?
Next, you andDr Cronenwett should be congratulated for the
efforts you have undertaken to keep this study group chugging and
producing continued clinical reports about various aspects of vas-
cular disease. You have nicely demonstrated that, despite my
frustrations in training young pups to be vascular surgeons, that
you can teach an old dog new tricks. You have shown an increasing
utilization of patching during endarterectomy during the years of
the report. I presume this change is related to the feedback
provided to your surgeons during the semiannual update meet-
ings.
Can you also assure me of some duplex ultrasound consisten-
cies across the 67 surgeons? You noted that contralateral stenosis
80% was associated with a higher rate of recurrent stenosis on the
operated side. This may reflect a difference in ultrasound criteria at
each site. How do we know that the ultrasound criteria for reste-
nosis are consistent and validated at each of these sites?
Finally, the primary point of your paper shows that the reste-
nosis rate is higher without patching and is also likely related to use
of the eversion technique (even though the numbers were too
small in this subgroup to make statistical statement) at 6% at 1 year
compared to 1% in the conventional (and most often patched)
group. This phenomenon needs further explanation, particularly
considering that your neighbors in Albany, NY, promote the
eversion technique as the best way to perform the procedure.
While I may need a geography lesson, Albany is close to your own
New England area, and we Southern folk may need more explana-
tion about why those trainees from Albany are not able to repro-duce the results of the mother ship. Are these surgeons in your
group just not performing the eversion technique in the correct
way to remove all the plaque and media to avoid the problem with
recurrent stenosis? Help us here.
Again, thank you for sending the manuscript to me well ahead
of the deadline for my review. You are to be congratulated for the
continued academic efforts to improve the quality of vascular care
for your region and around the United States.
Dr Goodney. Thank you very much, Dr Jordan. In regard to
your first question: should we surveil? The short answer is, I don’t
know. However, your question gave me a good idea about what
might be some subsequent research work. One could conceive that
you could utilize the restenosis rate fromourwork here as an input for
a decision analysis model and subsequently try to perform cost-
effective analysis to determine the cost-effectiveness of screening.
This is something we will work on in the future, certainly.
Secondly, about duplex criteria, our work is not a randomized
trial, of course, and we did not have a core lab. However, all the
vascular surgery practices that make up the VSGNE have ICAVL
(Intersocietal Commission for the Accreditation of Vascular Lab-
oratories) certified labs. While I can’t tell you offhand with cer-
tainty that everybody has exactly the same criteria for 80% to 99%,
they all indeed have been ICAVL certified.
The last question, about whether or not some surgeons are
doing eversions the right way, I have only been in practice for
about a year now, but even I know better than to point fingers
about how someone performs their carotids. I think that is an
interesting question. We have a relatively small sample, as I have
mentioned, of eversion endarterectomy. I think one of the impor-
tant findings, however, is that the surgeons that comprised the
procedures outcomes in this analysis were stable over time. It
wasn’t that the high restenosis surgeons left town, and that some-
body else took over. These changes represent essentially the same
cohort of surgeons, so we believe that the surgeons really did
change their practice patterns over time.
